M28 Capital Management LP
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 12, 2024), M28 Capital Management LP reported 11 stock positions worth $91.0 million. Its top holding was Wave Life Sciences (WVE) at 55.5% of the portfolio, followed by Invivyd (IVVD, 10.4%) and Rocket Pharmaceuticals (RCKT, 7.8%). Its holdings were unchanged from Q2 2024.
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001807489
- Portfolio Value
- $91.0M (Q3 2024)
- SEC Filing
- 0000902664-24-006434 ↗ filed Nov 12, 2024
Holdings Value
Holdings 11 stocks · $91.0M
| WVE Wave Life Sciences Ltd. | 55.55% | 6,164,548 | $50.5M | No change |
| IVVD Invivyd Inc. | 10.37% | 9,248,250 | $9.4M | No change |
| RCKT Rocket Pharmaceuticals Inc. | 7.83% | 385,680 | $7.1M | No change |
| GUTS Fractyl Health Inc. | 5.16% | 1,856,117 | $4.7M | No change |
| TGTX TG Therapeutics Inc. | 4.15% | 161,600 | $3.8M | No change |
| SWTX Springworks Therapeutics Inc. | 3.89% | 110,400 | $3.5M | No change |
| SLN Silence Therapeutics PLC-ADR | 3.70% | 185,100 | $3.4M | No change |
| BBIO Bridgebio Pharma Inc. | 3.39% | 121,200 | $3.1M | No change |
| CRIS Curis Inc. | 2.50% | 421,951 | $2.3M | No change |
| PRQR Proqr Therapeutics NV | 2.04% | 1,019,498 | $1.9M | No change |
| ARWR Arrowhead Pharmaceuticals Inc. | 1.43% | 67,400 | $1.3M | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $47.2M | WVE, IVVD, TGTX, ARWR, GUTS |
| Q1 2026 | 9 | $53.8M | WVE, IVVD, TGTX, ARWR, PRQR |
| Q4 2025 | 9 | $137.6M | WVE, IVVD, TGTX, ARWR, GUTS |
| Q3 2025 | 9 | $68.0M | WVE, IVVD, TGTX, GUTS, ARWR |
| Q2 2025 | 9 | $58.6M | WVE, IVVD, TGTX, GUTS, PRQR |
| Q1 2025 | 11 | $73.0M | WVE, TGTX, IVVD, BBIO, RCKT |
| Q4 2024 | 11 | $101.9M | WVE, TGTX, RCKT, IVVD, SWTX |
| Q3 2024 | 11 | $91.0M | WVE, IVVD, RCKT, GUTS, TGTX |
| Q2 2024 | 11 | $77.1M | WVE, IVVD, RCKT, GUTS, SWTX |
| Q1 2024 | 11 | $135.3M | WVE, IVVD, GUTS, RCKT, SLN |